| FDA Asks for More Data on Dynavax Technologies Corporation (DVAX ... - Lifescience-online |
|
|
... two INDs and may assist in finding a development path forward for HEPLISAV hepatitis B vaccine, not only in ESRD patients but also in healthy adults. ... |